Cyprus vs Kyrgyzstan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cyprus
83.0%
in 2025
Kyrgyzstan
84.0%
in 2025
Cyprus rank
104th
Kyrgyzstan rank
102nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cyprus
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 84.0% against 83.0% in Cyprus, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Kyrgyzstan ahead.
Cyprus ranks 104th and Kyrgyzstan ranks 102nd of 194 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Cyprus | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 40.5% | 27.6% | 12.9% | Cyprus |
| 2020s | 80.3% | 88.8% | 8.5% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cyprus or Kyrgyzstan?
- Kyrgyzstan, at 84.0% against 83.0% in Cyprus as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cyprus and Kyrgyzstan?
- 1.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Cyprus and Kyrgyzstan?
- 18 years are reported by both, from 2008 to 2025.
- How do Cyprus and Kyrgyzstan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cyprus ranks 104th and Kyrgyzstan ranks 102nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.